Review of GLP-1 Receptor Agonists in Psoriasis Save Know-it-now: GLP-1 RAs are not FDA-approved for psoriasis, but observational and trial data consistently show meaningful reductions in PASI scores particularly in obese patients likely through weight loss, adipose-driven inflammation reduction, and possible direct anti-inflammatory signalling
Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, Singh SS, Taylor HS (2019) Clinical diagnosis of endometriosis: a call to action
Do not treat the economic cost column as the refundable amount
The entire purpose of a control group is to isolate the supplement's effect from the natural effects of being in a study, receiving attention, and knowing your weight is being tracked
Avoid fried rice, tempura, sweet sauces
It attributes the resulting patchwork to cost containment pressure on strained state budgets, which pushes programs to prioritize the diabetes indication over weight management